Literature DB >> 23360614

Both low birthweight and high birthweight are associated with cognitive impairment in persons with schizophrenia and their first-degree relatives.

M Torniainen1, A Wegelius, A Tuulio-Henriksson, J Lönnqvist, J Suvisaari.   

Abstract

BACKGROUND: Both low birthweight and high birthweight have been associated with an increased risk for schizophrenia and cognitive impairments in the general population. We assessed the association between birthweight and cognitive performance in persons with schizophrenia and their unaffected first-degree relatives.
METHOD: We investigated a population-based family sample comprising persons with schizophrenia (n = 142) and their unaffected first-degree relatives (n = 277). Both patients and relatives were interviewed with the Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) and a comprehensive neuropsychological test battery was administered. Information on birthweight was obtained from obstetric records. We used generalized estimating equation (GEE) models to investigate the effect of birthweight, as a continuous variable, on cognitive functioning, adjusting for within-family correlation and relevant covariates.
RESULTS: Both low birthweight and high birthweight were associated with lower performance in visuospatial reasoning, processing speed, set-shifting and verbal and visual working memory among persons with schizophrenia and their unaffected first-degree relatives compared to individuals with birthweight in the intermediate range. The group × birthweight interactions were non-significant.
CONCLUSIONS: Both low birthweight and high birthweight are associated with deficits in cognition later in life. Schizophrenia does not seem to modify the relationship between birthweight and cognition in families with schizophrenia.

Entities:  

Mesh:

Year:  2013        PMID: 23360614     DOI: 10.1017/S0033291713000032

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  3 in total

Review 1.  Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells.

Authors:  Samuel K Powell; Callan P O'Shea; Sara Rose Shannon; Schahram Akbarian; Kristen J Brennand
Journal:  Adv Neurobiol       Date:  2020

2.  Neuropsychological Impairment in Prodromal, First-Episode, and Chronic Psychosis: Assessing RBANS Performance.

Authors:  TianHong Zhang; HuiJun Li; William S Stone; Kristen A Woodberry; Larry J Seidman; YingYing Tang; Qian Guo; KaiMing Zhuo; ZhenYing Qian; HuiRu Cui; YiKang Zhu; LiJuan Jiang; Annabelle Chow; YunXiang Tang; ChunBo Li; KaiDa Jiang; ZhengHui Yi; ZePing Xiao; JiJun Wang
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

3.  Perinatal complications and executive dysfunction in early-onset schizophrenia.

Authors:  Charlotte M Teigset; Christine Mohn; Bjørn Rishovd Rund
Journal:  BMC Psychiatry       Date:  2020-03-04       Impact factor: 3.630

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.